Cefazolin as a cause of leukocytoclastic vasculitis

Leukocytoclastic vasculitis (LCV) is a cutaneous small vessel vasculitis characterized by cutaneous manifestations in the form of palpable purpura, and rarely bullae, vesicles, and ulcerations. Although rare, cephalosporins such as cefazolin, should be recognized to have a potential to trigger LCV.

Detalles Bibliográficos
Autores principales: Ali, Naveed, Karia, Nidhi, Goldhahn, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458023/
https://www.ncbi.nlm.nih.gov/pubmed/28588872
http://dx.doi.org/10.1002/ccr3.992
_version_ 1783241665942650880
author Ali, Naveed
Karia, Nidhi
Goldhahn, Richard
author_facet Ali, Naveed
Karia, Nidhi
Goldhahn, Richard
author_sort Ali, Naveed
collection PubMed
description Leukocytoclastic vasculitis (LCV) is a cutaneous small vessel vasculitis characterized by cutaneous manifestations in the form of palpable purpura, and rarely bullae, vesicles, and ulcerations. Although rare, cephalosporins such as cefazolin, should be recognized to have a potential to trigger LCV.
format Online
Article
Text
id pubmed-5458023
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-54580232017-06-06 Cefazolin as a cause of leukocytoclastic vasculitis Ali, Naveed Karia, Nidhi Goldhahn, Richard Clin Case Rep Clinical Images Leukocytoclastic vasculitis (LCV) is a cutaneous small vessel vasculitis characterized by cutaneous manifestations in the form of palpable purpura, and rarely bullae, vesicles, and ulcerations. Although rare, cephalosporins such as cefazolin, should be recognized to have a potential to trigger LCV. John Wiley and Sons Inc. 2017-05-12 /pmc/articles/PMC5458023/ /pubmed/28588872 http://dx.doi.org/10.1002/ccr3.992 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Images
Ali, Naveed
Karia, Nidhi
Goldhahn, Richard
Cefazolin as a cause of leukocytoclastic vasculitis
title Cefazolin as a cause of leukocytoclastic vasculitis
title_full Cefazolin as a cause of leukocytoclastic vasculitis
title_fullStr Cefazolin as a cause of leukocytoclastic vasculitis
title_full_unstemmed Cefazolin as a cause of leukocytoclastic vasculitis
title_short Cefazolin as a cause of leukocytoclastic vasculitis
title_sort cefazolin as a cause of leukocytoclastic vasculitis
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458023/
https://www.ncbi.nlm.nih.gov/pubmed/28588872
http://dx.doi.org/10.1002/ccr3.992
work_keys_str_mv AT alinaveed cefazolinasacauseofleukocytoclasticvasculitis
AT karianidhi cefazolinasacauseofleukocytoclasticvasculitis
AT goldhahnrichard cefazolinasacauseofleukocytoclasticvasculitis

Ejemplares similares